Krsnaa Diagnostics Limited Stock Price Today (NSE: KRSNAA)
Fundamental Score
Krsnaa Diagnostics Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Krsnaa Diagnostics Limited share price today is ₹564.80, up +4.55% on NSE/BSE as of 25 August 2026. Krsnaa Diagnostics Limited (KRSNAA) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹1.78K (Cr). The 52-week high for KRSNAA share price is ₹894.40 and the 52-week low is ₹515.00. At a P/E ratio of 21.62x, KRSNAA is currently trading below its industry average P/E of 42.23x. The company has a Return on Equity (ROE) of 10.89% and a debt-to-equity ratio of 0.55.
Krsnaa Diagnostics Limited Share Price Chart — NSE/BSE Historical Performance
Krsnaa Diagnostics Limited share price chart: 4.19% return over the past month. 52-week high ₹894.40, 52-week low ₹515.00.
Krsnaa Diagnostics Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹564.00 | ₹569.10 | ₹560.00 | ₹564.80 | 22.31K (Cr) | |
| ₹560.00 | ₹563.00 | ₹537.10 | ₹540.20 | 85.64K (Cr) | |
| ₹557.95 | ₹586.00 | ₹557.00 | ₹575.30 | 2.73L (Cr) | |
| ₹566.35 | ₹577.70 | ₹534.00 | ₹556.75 | 83.06K (Cr) | |
| ₹575.10 | ₹577.00 | ₹563.20 | ₹573.75 | 1.48L (Cr) | |
| ₹567.00 | ₹578.35 | ₹557.30 | ₹574.80 | 82.34K (Cr) | |
| ₹560.95 | ₹571.00 | ₹560.05 | ₹567.60 | 78.67K (Cr) | |
| ₹561.65 | ₹566.00 | ₹555.05 | ₹560.85 | 42.69K (Cr) | |
| ₹560.00 | ₹563.30 | ₹553.50 | ₹559.90 | 33.33K (Cr) | |
| ₹563.80 | ₹566.95 | ₹557.35 | ₹561.45 | 62.74K (Cr) |
Krsnaa Diagnostics Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹529.00 | ₹586.00 | ₹526.55 | ₹564.80 | +6.77% | |
| ₹544.30 | ₹579.00 | ₹520.80 | ₹527.45 | -3.10% | |
| ₹550.00 | ₹561.00 | ₹528.00 | ₹543.80 | -1.13% | |
| ₹597.75 | ₹622.55 | ₹533.00 | ₹549.45 | -8.08% | |
| ₹530.00 | ₹630.35 | ₹530.00 | ₹588.75 | +11.08% | |
| ₹629.70 | ₹637.90 | ₹515.00 | ₹520.30 | -17.37% | |
| ₹695.35 | ₹733.10 | ₹621.00 | ₹635.45 | -8.61% | |
| ₹715.00 | ₹775.00 | ₹692.85 | ₹712.10 | -0.41% | |
| ₹804.00 | ₹817.40 | ₹703.00 | ₹721.35 | -10.28% | |
| ₹770.05 | ₹838.00 | ₹716.15 | ₹810.75 | +5.29% | |
| ₹758.00 | ₹848.10 | ₹754.95 | ₹776.70 | +2.47% | |
| ₹788.70 | ₹894.40 | ₹752.00 | ₹756.80 | -4.04% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Krsnaa Diagnostics Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Krsnaa Diagnostics Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of KRSNAA across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Strong Operating Margins (28.11%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 21.62 vs Industry: 42.23)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (22.05%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Healthy Liquidity Position (Current Ratio: 2.68)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Profit Decline Concern (-19.34%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Negative Free Cash Flow (₹-353.86 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (27.11%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Krsnaa Diagnostics Limited vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Krsnaa Diagnostics Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Krsnaa Diagnostics LimitedKrsnaa Diagnost...Selected✓ KRSNAA • 543328 | 31.9/100 | ₹564.80₹565 | ₹1777.47₹1777.47 | 21.62Average 21.6 Average | 10.89%Average 10.89% Average | 13.05%Average 13.05% Average | 0.55Good 0.5 Good | — — | — — | 0.50% |
Dr. Lal Path Labs Ltd.Dr. Lal Path La... LALPATHLAB • 539524 | 57.7/100 | ₹1913.70₹1914 | ₹28908.91₹28908.91 | 53.35Average 53.3 Average | 21.57%Excellent 21.57% Excellent | 27.62%Excellent 27.62% Excellent | 0.00Excellent 0.0 Excellent | 11.60%Good 11.60% Good | 11.81%Good 11.81% Good | 0.81% |
Vijaya Diagnostic Centre LimitedVijaya Diagnost... VIJAYA • 543350 | 67.8/100 | ₹1483.40₹1483 | ₹14307.85₹14307.85 | 76.31Average 76.3 Average | 19.74%Good 19.74% Good | 21.32%Excellent 21.32% Excellent | 0.00Excellent 0.0 Excellent | — — | — — | 0.14% |
Metropolis Healthcare LimitedMetropolis Heal... METROPOLIS • 542650 | 57.9/100 | ₹566.70₹567 | ₹11858.49₹11858.49 | 58.81Average 58.8 Average | 13.36%Average 13.36% Average | 16.80%Good 16.80% Good | 0.01Excellent 0.0 Excellent | 0.74%Average 0.74% Average | 10.52%Good 10.52% Good | 0.35% |
Thyrocare Technologies LimitedThyrocare Techn... THYROCARE • 539871 | 46.7/100 | ₹596.05₹596 | ₹8420.27₹8420.27 | 47.76Average 47.8 Average | 28.80%Excellent 28.80% Excellent | 35.47%Excellent 35.47% Excellent | 0.00Excellent 0.0 Excellent | — — | 10.88%Good 10.88% Good | 1.76% |
Suraksha Diagnostic LimitedSuraksha Diagno... SURAKSHA • 544293 | 56.2/100 | ₹317.85₹318 | ₹1359.30₹1359.30 | 37.97Average 38.0 Average | 14.11%Average 14.11% Average | 16.82%Good 16.82% Good | 0.01Excellent 0.0 Excellent | — — | — — | 0.00% |
One Global Service Provider LimitedOne Global Serv... ONEGLOBAL • 514330 | 82.2/100 | ₹546.20₹546 | ₹1178.25₹1178.25 | — — | — — | — — | — — | — — | — — | 0.00% |
3B Blackbio Dx Limited3B Blackbio Dx ... 3BBLACKBIO • 532067 | 60.3/100 | ₹1262.40₹1262 | ₹1079.13₹1079.13 | — — | — — | — — | — — | — — | — — | 0.31% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 39/100 | ₹301.45₹301 | ₹1035.54₹1035.54 | 539.34Average 539.3 Average | 0.29%Poor 0.29% Poor | -0.05%Poor -0.05% Poor | 0.04Excellent 0.0 Excellent | 16.91%Excellent 16.91% Excellent | 19.09%Excellent 19.09% Excellent | 0.00% |
49.4/100 | ₹220.15₹220 | ₹600.78₹600.78 | 20.55Average 20.6 Average | 19.92%Good 19.92% Good | 23.27%Excellent 23.27% Excellent | 0.31Excellent 0.3 Excellent | — — | — — | 0.00% | |
Aspira Pathlab & Diagnostics LimitedAspira Pathlab ... ASPIRA • 540788 | 11.9/100 | ₹93.70₹94 | ₹88.52₹88.52 | 1770.34Average 1770.3 Average | 0.51%Poor 0.51% Poor | 2.84%Poor 2.84% Poor | 0.27Excellent 0.3 Excellent | -48.50%Poor -48.50% Poor | 10.43%Good 10.43% Good | 0.00% |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr. Lal Path Labs Ltd. share price28908.91 Cr
- Vijaya Diagnostic Centre Limited share price14307.85 Cr
- Metropolis Healthcare Limited share price11858.49 Cr
- Thyrocare Technologies Limited share price8420.27 Cr
- Suraksha Diagnostic Limited share price1359.30 Cr
Krsnaa Diagnostics Limited PE Ratio History
Historical price-to-earnings ratio for KRSNAA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹23.56 | ₹721.35 | 30.6x |
| FY 2024 | ₹17.31 | ₹885.50 | 51.2x |
| FY 2023 | ₹19.29 | ₹706.00 | 36.6x |
| FY 2022 | ₹22.88 | ₹460.90 | 20.1x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Krsnaa Diagnostics Limited Dividend History
Annual cash dividends paid by KRSNAA — dividend yield 0.50%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹8.07 Cr |
| FY 2024 | ₹8.63 Cr |
| FY 2023 | ₹7.85 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Krsnaa Diagnostics Limited Quarterly Performance
Latest quarterly metrics for KRSNAA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
22.05%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-19.34%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Krsnaa Diagnostics Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for KRSNAA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Krsnaa Diagnostics Limited Financial Statements
Annual income statement, balance sheet and cash flow for Krsnaa Diagnostics Limited (KRSNAA) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Krsnaa Diagnostics Limited
About KRSNAA (Krsnaa Diagnostics Limited)
Krsnaa Diagnostics Ltd is a prominent healthcare service provider in India, dedicated to delivering accessible and reliable diagnostic solutions. The company functions as a compreh...ensive diagnostic center, providing a broad spectrum of services encompassing both radiology and pathology. Its radiology offerings feature advanced imaging modalities such as computed tomography (CT) scans, magnetic resonance imaging (MRI), X-rays, and ultrasounds, catering to diverse diagnostic requirements. Alongside its imaging capabilities, Krsnaa Diagnostics provides a comprehensive suite of pathology services, incorporating extensive laboratory testing, convenient home sample collection, and preventive health checkups. Beyond its core diagnostic services, Krsnaa Diagnostics leverages technology to extend its reach and enhance service delivery through teleradiology and telepathology. These remote consultation and diagnostic reporting services enable timely access to expert interpretations, particularly in underserved areas. The company's commitment to innovation is further exemplified by its provision of specialized diagnostic services, including ophthalmic tests, mammography, dental imaging, stress tests, and dual-energy X-ray absorptiometry (DEXA) scans. This multifaceted approach underscores Krsnaa Diagnostics' dedication to offering a complete diagnostic solution to patients and healthcare providers alike. Krsnaa Diagnostics prides itself on its unwavering commitment to quality, accuracy, and patient-centric care. By combining state-of-the-art technology, a highly skilled team of medical professionals, and a widespread network of diagnostic centers, the company strives to empower individuals with the knowledge necessary to make informed healthcare decisions. Krsnaa Diagnostics focuses on expanding its geographical footprint and broadening its service offerings to address the evolving healthcare needs of the Indian population. Through its unwavering dedication to excellence, Krsnaa Diagnostics plays a crucial role in improving the overall health and well-being of the communities it serves.
Company Details
Key Leadership
Corporate Events
KRSNAA Share Price: Frequently Asked Questions
What is the current share price of Krsnaa Diagnostics Limited?
Krsnaa Diagnostics Limited (KRSNAA) trades at ₹564.80 on NSE and BSE. Market cap ₹1.78K (Cr). Educational data only.
What is the P/E ratio of Krsnaa Diagnostics Limited?
Krsnaa Diagnostics Limited has a P/E of 21.62x vs industry average 42.23x.
What is the Bull Run score for Krsnaa Diagnostics Limited?
Krsnaa Diagnostics Limited has a Bull Run score of 31.9/100 based on 25+ financial parameters.
Does Krsnaa Diagnostics Limited pay dividends?
Krsnaa Diagnostics Limited has a dividend yield of 0.50%. Past dividends don't guarantee future payments.
What is the ROE of Krsnaa Diagnostics Limited?
Krsnaa Diagnostics Limited has ROE of 10.89%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Krsnaa Diagnostics Limited?
Krsnaa Diagnostics Limited has debt-to-equity of 0.55.
Is Krsnaa Diagnostics Limited a good investment?
Bull Run gives Krsnaa Diagnostics Limited a score of 31.9/100. This is not investment advice — consult a SEBI-registered advisor.